Anti-Staphylococcal Biofilm Effects of Human Cathelicidin Peptides

ACS Medicinal Chemistry Letters

Volumn 7, Issue 1, 2016, Pages 117-121

  Mishra, Biswajit ^a   Golla, Radha M ^a   Lau, Kyle ^a   Lushnikova, Tamara ^a   Wang, Guangshun ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

17BIPHE2; attachment mutants; Biofilms; GF 17; LL 37; Staphylococcus aureus

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DAPTOMYCIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; CONCENTRATION (PARAMETERS); DRUG EFFECT; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MUTANT; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TRANSPOSON;

EID: 84955494348     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.5b00433     Document Type: Article

References (34)

1. David, M. Z.; Daum, R. S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic Clin. Microbiol. Rev. 2010, 23, 616-687 10.1128/CMR.00081-09
2. Otto, M. Staphylococcal biofilms Curr. Top. Microbiol. Immunol. 2008, 322, 207-228 10.1007/978-3-540-75418-3-10
3. Mishra, B.; Lushnikova, T.; Wang, G. Small lipopeptides possess antibiofilm capability comparable to daptomycin and vancomycin RSC Adv. 2015, 5, 59758-59769 10.1039/C5RA07896B
4. Chen, M.; Yu, Q.; Sun, H. Novel strategies for the prevention and treatment of biofilm related infections Int. J. Mol. Sci. 2013, 14, 18488-18501 10.3390/ijms140918488
5. Wang, G.; Li, X.; Wang, Z. APD2: the updated antimicrobial peptide database and its application in peptide design Nucleic Acids Res. 2009, 37, D933-7 10.1093/nar/gkn823
6. Wang, G. Human antimicrobial peptides and proteins Pharmaceuticals 2014, 7, 545-594 10.3390/ph7050545
7. Wang, G. Antimicrobial Peptides: Discovery. In Design and Novel Therapeutic Strategies; CABI: Oxfordshire, U.K., 2010.
8. Cederlund, A.; Gudmundsson, G. H.; Agerberth, B. Antimicrobial peptides important in innate immunity FEBS J. 2011, 278, 3942-3951 10.1111/j.1742-4658.2011.08302.x
9. Vandamme, D.; Landuyt, B.; Luyten, W.; Schoofs, L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide Cell. Immunol. 2012, 280, 22-35 10.1016/j.cellimm.2012.11.009
10. Lehrer, R. I.; Ganz, T. Cathelicidins: a family of endogenous antimicrobial peptides Curr. Opin. Hematol. 2002, 9, 18-22 10.1097/00062752-200201000-00004
11. Wang, G.; Mishra, B.; Epand, R. F.; Epand, R. M. High-quality 3D structures shine light on antibacterial, antibiofilm and antiviral activities of human cathelicidin LL-37 and its fragments Biochim. Biophys. Acta, Biomembr. 2014, 1838, 2160-2172 10.1016/j.bbamem.2014.01.016
12. Overhage, J.; Campisano, A.; Bains, M.; Torfs, E. C.; Rehm, B. H.; Hancock, R. E. Human host defense peptide LL-37 prevents bacterial biofilm formation Infect. Immun. 2008, 76, 4176-4182 10.1128/IAI.00318-08
13. Hell, E.; Giske, C. G.; Nelson, A.; Romling, U.; Marchini, G. Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis Lett. Appl. Microbiol. 2010, 50, 211-215 10.1111/j.1472-765X.2009.02778.x
14. Dean, S. N.; Bishop, B. M.; van Hoek, M. L. Natural and synthetic cathelicidin peptides with anti-microbial and antibiofilm activity against Staphylococcus aureus BMC Microbiol. 2011, 11, 114-2180-11-114 10.1186/1471-2180-11-114
15. Haisma, E. M.; de Breij, A.; Chan, H.; van Dissel, J. T.; Drijfhout, J. W.; Hiemstra, P. S.; El Ghalbzouri, A.; Nibbering, P. H. LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents Antimicrob. Agents Chemother. 2014, 58, 4411-4419 10.1128/AAC.02554-14
16. Feng, X.; Sambanthamoorthy, K.; Palys, T.; Paranavitana, C. The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii Peptides 2013, 49, 131-137 10.1016/j.peptides.2013.09.007
17. Dosler, S.; Karaaslan, E. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides Peptides 2014, 62, 32-37 10.1016/j.peptides.2014.09.021
18. Dean, S. N.; Walsh, C.; Goodman, H.; van Hoek, M. L. Analysis of mixed biofilm (Staphylococcus aureus and Pseudomonas aeruginosa) by laser ablation electrospray ionization mass spectrometry Biofouling 2015, 31, 151-161 10.1080/08927014.2015.1011067
19. Wnorowska, U.; Niemirowicz, K.; Myint, M.; Diamond, S. L.; Wroblewska, M.; Savage, P. B.; Janmey, P. A.; Bucki, R. Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58 Antimicrob. Agents Chemother. 2015, 59, 3808-3815 10.1128/AAC.00421-15
20. Dean, S. N.; Bishop, B. M.; van Hoek, M. L. Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37 Front. Microbiol. 2011, 2, 128 10.3389/fmicb.2011.00128
21. Pompilio, A.; Scocchi, M.; Pomponio, S.; Guida, F.; Di Primio, A.; Fiscarelli, E.; Gennaro, R.; Di Bonaventura, G. Antibacterial and antibiofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients Peptides 2011, 32, 1807-1814 10.1016/j.peptides.2011.08.002
22. Di Luca, M.; Maccari, G.; Maisetta, G.; Batoni, G. BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015, 31, 193-199 10.1080/08927014.2015.1021340
23. Wang, G.; Hanke, M. L.; Mishra, B.; Lushnikova, T.; Heim, C. E.; Chittezham Thomas, V.; Bayles, K. W.; Kielian, T. Transformation of human cathelicidin LL-37 into selective, stable, and potent antimicrobial compounds ACS Chem. Biol. 2014, 9, 1997-2002 10.1021/cb500475y
24. Li, X.; Li, Y.; Han, H.; Miller, D. W.; Wang, G. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region J. Am. Chem. Soc. 2006, 128, 5776-5785 10.1021/ja0584875
25. Wang, G. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles J. Biol. Chem. 2008, 283, 32637-32643 10.1074/jbc.M805533200
26. Epand, R. F.; Wang, G.; Berno, B.; Epand, R. M. Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37 Antimicrob. Agents Chemother. 2009, 53, 3705-3714 10.1128/AAC.00321-09
27. Fey, P. D.; Endres, J. L.; Yajjala, V. K.; Widhelm, T. J.; Boissy, R. J.; Bose, J. L.; Bayles, K. W. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes mBio 2013, 4, e00537-12 10.1128/mBio.00537-12
28. Moormeier, D. E.; Bose, J. L.; Horswill, A. R.; Bayles, K. W. Temporal and stochastic control of Staphylococcus aureus biofilm development mBio 2014, 5, e01341-14 10.1128/mBio.01341-14
29. Archer, N. K.; Mazaitis, M. J.; Costerton, J. W.; Leid, J. G.; Powers, M. E.; Shirtliff, M. E. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease Virulence. 2011, 2, 445-459 10.4161/viru.2.5.17724
30. Houston, P.; Rowe, S. E.; Pozzi, C.; Waters, E. M.; O'Gara, J. P. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype Infect. Immun. 2011, 79, 1153-1165 10.1128/IAI.00364-10
31. Foster, T. J.; Hook, M. Surface protein adhesins of Staphylococcus aureus Trends Microbiol. 1998, 6, 484-488 10.1016/S0966-842X(98)01400-0
32. Foulston, L.; Elsholz, A. K.; DeFrancesco, A. S.; Losick, R. The extracellular matrix of Staphylococcus aureus biofilms comprises cytoplasmic proteins that associate with the cell surface in response to decreasing pH mBio 2014, 5, e01667-14 10.1128/mBio.01667-14
33. Wang, G.; Mishra, B.; Lau, K.; Lushnikova, T.; Golla, R.; Wang, X. Antimicrobial peptides in 2014 Pharmaceuticals 2015, 8, 123-150 10.3390/ph8010123
34. Wang, G.; Epand, R. F.; Mishra, B.; Lushnikova, T.; Thomas, V. C.; Bayles, K. W.; Epand, R. M. Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37 Antimicrob. Agents Chemother. 2012, 56, 845-856 10.1128/AAC.05637-11